Key result
Tiodazosin reduces mean BP in ~70% of essential hypertension patients but causes notable side effects.
Why the study?
The long-term hemodynamic and systemic effects of tiodazosin in patients with essential hypertension were evaluated due to its structural similarity to prazosin and unique vasodilator properties.
Does tiodazosin improve hemodynamics and lower blood pressure in patients with essential hypertension?
Population
10 patients with essential hypertension
Comparison
Tiodazosin treatment with no comparator
Design
Case series
Follow-up
10 weeks
Authors
Loading...
May warrant caution due to side effects; case-report data leave open any advantage over established agents in essential hypertension.
Does tiodazosin improve hemodynamics and lower blood pressure in patients with essential hypertension?
Tiodazosin lowers blood pressure in most patients with essential hypertension but has significant side effects and offers little advantage over existing therapies.
Vardan et al. (1983) studied essential hypertension (n=10). Tiodazosin was evaluated on significant reduction in intra-arterial mean blood pressure. Tiodazosin therapy for 10 weeks reduced intra-arterial mean blood pressure in 70% of patients with essential hypertension, but caused notable side effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: